Crossmark Global Holdings’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Crossmark Global Holdings's ABMD Position: Q4 2022 in Review
Crossmark Global Holdings sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,570 shares — an estimated $631K sold.
Crossmark Global Holdings first reported a position in ABMD in Q3 2016 and held it in 22 quarters. The position peaked at $3.17M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Crossmark Global Holdings reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Crossmark Global Holdings sold 2,570 Abiomed Inc shares in Q4 2022, an estimated $631K.
- Crossmark Global Holdings first reported a position in Abiomed Inc in Q3 2016 and held it in 22 quarters.
- Crossmark Global Holdings's Abiomed Inc position peaked at $3.17M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Crossmark Global Holdings's 13F filing for Q4 2022, filed 19 Jan 2023.